The DOI matches its Crossref record; 58 of the 61 references it cites were found in a registry or an index.
BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function
Open accessAbstract
BRCA1 interacts in vivo with a novel protein, BACH1, a member of the DEAH helicase family. BACH1 binds directly to the BRCT repeats of BRCA1. A BACH1 derivative, bearing a mutation in a residue that was essential for catalytic function in other helicases, interfered with normal double-strand break repair in a manner that was dependent on its BRCA1 binding function. Thus, BACH1/BRCA1 complex formation contributes to a key BRCA1 activity. In addition, germline BACH1 mutations affecting the helicase domain were detected in two early-onset breast cancer patients and not in 200 matched controls. Thus, it is conceivable that, like BRCA1, BACH1 is a target of germline cancer-inducing mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In particular, overexpression of the helicase-inactive K52R mutant in cells with wild-type FANCJ resulted in the accumulation of unrepaired DNA breaks when analyzed by pulse field electrophoresis [8], as well as reduced homologous recombination following double strand break induction [69].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“The purified 130-kDa protein was subject to tandem mass spectrometry and the FANCJ gene was cloned and found to consist of 20 exons spanning greater than 180 kb of genomic sequence in chromosome 17q22.”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Furthermore, unlike the classic paradigm for tumor suppressor genes, in which the tumor exclusively lacks the wild-type allele, tumors of individuals who were heterozygous for these two germline FANCJ mutations did not show loss of the corresponding wild-type allele [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“For example, the P47A variant identified in 2001 [8] and shown to disrupt FANCJ enzyme function [56] was found in the controls of a subsequent study and considered to be unrelated to breast cancer [44].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Among the proteins identified was a protein of approximately 130 kDa that failed to interact with a BRCA1, harboring patient mutations within the BRCT motifs (P1749R and M1775R) [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Most notably, the protein product had strong homology to the catalytic and nucleotide-binding domains of other members within the DEAH helicase family, including the xeroderma pigmentosum complimenting group D (XPD) [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“In keeping with this suggestion, two patients with a family history and early-onset breast cancer were identified that had discrete germline sequence changes, P47A and M299I, targeting the helicase domain of FANCJ [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“Moreover, the aforementioned P47A mutant had a reduced protein half-life when overexpressed in tissue culture cells [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
In the citing paper
“BRCA1 clinical mutations target the BRCT region required for FANCJ binding [8].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
High-Efficiency Transformation of Mammalian Cells by Plasmid DNA
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Self-citationBrca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Carney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Le Beau, M., Yates, J. R., Hays, L., Morgan, W. F., & Petrini, J. H. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81175-7 · Cited by 1,226
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
Stewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G. J., Raams, A., Byrd, P. J., Petrini, J. H. J., & Taylor, A. M. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81547-0 · Cited by 1,060
Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B., & Livingston, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.8.869 · Cited by 1,045
Self-citationDynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Self-citation
Research works printed but not linked: 1
- Ma, 1994, Mutational analysis of ERCC3, which is involved in DNA repair and transcription initiation, Mol. Cell. Biol., 14, 4126, 10.1128/MCB.14.6.4126 · DOI
Cited by
Sorted by citations
Items 201–300 of 676
The DNA double-strand break response pathway: becoming more BRCAish than ever
Ting, N. S. Y., & Lee, W. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.026 · Cited by 67
T-box transcription factors in cancer biology
Wansleben, S. M., Peres, J., Hare, S., Goding, C. R., & Prince, S. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.08.004 · Cited by 65
Pardo, I., Lillemoe, H. A., Blosser, R. J., Choi, M.-R., Sauder, C. A. M., Doxey, D. K., Mathieson, T., Hancock, B. A., Baptiste, D. F., Atale, R. V., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3627 · Cited by 61
Fanconi anemia proteins stabilize replication forks
Wang, L. C., Stone, S., Hoatlin, M. E., & Gautier, J. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.08.005 · Cited by 67
DNA repair mechanisms protect our genome from carcinogenesis
Moraes, M. C. S. (2012) · Frontiers in Bioscience · doi:10.2741/3992 · Cited by 64
Pagano, G., Talamanca, A. A., Castello, G., Pallardó, F. V., Zatterale, A., & Degan, P. (2011) · Biological Chemistry · doi:10.1515/bc-2011-227 · Cited by 64
DHX9-dependent recruitment of BRCA1 to RNA promotes DNA end resection in homologous recombination
Chakraborty, P., & Hiom, K. J. (2021) · Nature Communications · doi:10.1038/s41467-021-24341-z · Cited by 67
FANCI Protein Binds to DNA and Interacts with FANCD2 to Recognize Branched Structures
Yuan, F., Hokayem, J. A. E., Zhou, W., & Zhang, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016006 · Cited by 64
Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families
Kang, P. C. E., Mariapun, S., Phuah, S. Y., Lim, L. S., Liu, J., Yoon, S., Thong, M., Taib, N. A. M., Yip, C. H., & Teo, S. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1018-5 · Cited by 64
Nikkilä, J., Coleman, K. A., Morrissey, D., Pylkäs, K., Erkko, H., Messick, T. E., Karppinen, S.-M., Amelina, A., Winqvist, R., & Greenberg, R. A. (2009) · Oncogene · doi:10.1038/onc.2009.33 · Cited by 63
Fanconi anemia and breast cancer susceptibility meet again
Levy‐Lahad, E. (2010) · Nature Genetics · doi:10.1038/ng0510-368 · Cited by 63
BRCA Gene Structure and Function in Tumor Suppression
Murphy, C. G., & Moynahan, M. E. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181cf0204 · Cited by 63
Disease-causing missense mutations in human DNA helicase disorders
Suhasini, A. N., & Brosh, R. M. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.12.004 · Cited by 63
Bharti, S. K., Khan, I., Banerjee, T., Sommers, J. A., Wu, Y., & Brosh, R. M. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1569-4 · Cited by 61
Au, W. W. Y., & Henderson, B. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408879200 · Cited by 61
A ChIP–chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response
Frontini, M., Vijayakumar, M., Garvin, A. J., & Clarke, N. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1051 · Cited by 63
The Fanconi anemia pathway and ubiquitin
Jacquemont, C. F., & Taniguchi, T. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s10 · Cited by 63
Rare BRIP1 Missense Alleles Confer Risk for Ovarian and Breast Cancer
Moyer, C. L., Ivanovich, J. L., Gillespie, J. L., Doberstein, R., Radke, M. R., Richardson, M. E., Kaufmann, S. H., Swisher, E. M., & Goodfellow, P. J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1991 · Cited by 62
Functional Impact of Missense Variants in BRCA1 Predicted by Supervised Learning
Karchin, R., Monteiro, Á. N. A., Tavtigian, S. V., Carvalho, M. A., & Šali, A. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030026 · Cited by 61
Ertych, N., Stolz, A., Valerius, O., Braus, G. H., & Bastians, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525129113 · Cited by 63
Targeting the FANCJ–BRCA1 interaction promotes a switch from recombination to polη-dependent bypass
Xie, J., Litman, R., Wang, S., Peng, M., Guillemette, S., Rooney, T., & Cantor, S. B. (2010) · Oncogene · doi:10.1038/onc.2010.18 · Cited by 60
Self-citationThe Fanconi anemia pathway and ICL repair: implications for cancer therapy
Wang, L. C., & Gautier, J. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.502166 · Cited by 63
Left-Right Asymmetry in Embryonic Development and Breast Cancer: Common Molecular Determinants?
Wilting, J., & Hagedorn, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711798347252 · Cited by 59
Song, H., Ramus, S. J., Kjær, S. K., Høgdall, E. V. S., DiCioccio, R. A., Whittemore, A. S., McGuire, V. M., Høgdall, C. K., Jacobs, I. J., Easton, D. F., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000268 · Cited by 60
Solyom, S., Aressy, B., Pylkäs, K., Patterson-Fortin, J., Hartikainen, J. M., Kallioniemi, A., Kauppila, S., Nikkilä, J., Kosma, V.-M., Mannermaa, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003223 · Cited by 59
Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences
Burren, O. S., Dhindsa, R. S., Deevi, S. V. V., Wen, S., Nag, A., Mitchell, J., Hu, F., Loesch, D. P., Smith, K. R., Razdan, N., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01884-7 · Cited by 59
Next-Generation Sequencing for Inherited Breast Cancer Risk: Counseling through the Complexity
Rainville, I. R., & Rana, H. Q. (2014) · Current Oncology Reports · doi:10.1007/s11912-013-0371-z · Cited by 61
Redistribution of BRCA1 among Four Different Protein Complexes following Replication Blockage
Chiba, N., & Parvin, J. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105227200 · Cited by 60
Fanconi anemia and Bloom's syndrome crosstalk through FANCJ–BLM helicase interaction
Suhasini, A. N., & Brosh, R. M. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.09.003 · Cited by 57
Dual role of CDKs in DNA repair: To be, or not to be
Yata, K., & Esashi, F. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.002 · Cited by 62
Shen, Y., & Tong, L. (2008) · Biochemistry · doi:10.1021/bi800314m · Cited by 60
BRCA1 and Its Network of Interacting Partners
Christou, C. M., & Kyriacou, K. C. (2013) · Biology · doi:10.3390/biology2010040 · Cited by 58
Fanconi Anemia Group J Helicase and MRE11 Nuclease Interact To Facilitate the DNA Damage Response
Suhasini, A. N., Sommers, J. A., Muniandy, P. A., Coulombe, Y., Cantor, S. B., Masson, J., Seidman, M. M., & Brosh, R. M. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01256-12 · Cited by 57
Self-citationDatta, A., & Brosh, R. M. (2019) · Genes · doi:10.3390/genes10020170 · Cited by 56
Chakraborty, P., & Große, F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq240 · Cited by 54
BRCA1 and p53: compensatory roles in DNA repair
Hartman, A., & Ford, J. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0477-0 · Cited by 62
Functional assays for BRCA1 and BRCA2
Carvalho, M. A., Couch, F. J., & Monteiro, Á. N. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.08.002 · Cited by 58
Rutter, J. L., Smith, A. M., Dávila, M. R., Sigurdson, A. J., Giusti, R. M., Pineda, M. A., Doody, M. M., Tucker, M. A., Greene, M. H., Zhang, J., et al. (2003) · Human Mutation · doi:10.1002/humu.10238 · Cited by 55
Suhasini, A. N., Sommers, J. A., Mason, A. C., Voloshin, O. N., Camerini‐Otero, R. D., Wold, M. S., & Brosh, R. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.012229 · Cited by 53
Peng, M., Xie, J., Ucher, A. J., Stavnezer, J., & Cantor, S. B. (2014) · The EMBO Journal · doi:10.15252/embj.201387530 · Cited by 54
Self-citationCybulski, K. E., & Howlett, N. G. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15818 · Cited by 53
Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer
Lewis, A., Flanagan, J. M., Marsh, A. J., Pupo, G. M., Mann, G. J., Spurdle, A. B., Lindeman, G. J., Visvader, J. E., Brown, M. A., & Chenevix‐Trench, G. (2005) · Breast Cancer Research · doi:10.1186/bcr1336 · Cited by 54
Gene expression in inherited breast cancer
Hedenfalk, I. A., Ringnér, M., Trent, J. M., & Borg, Å. (2002) · Advances in cancer research · doi:10.1016/s0065-230x(02)84001-5 · Cited by 51
Pageau, G. J., & Lawrence, J. B. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200602055 · Cited by 53
Breast Cancer Susceptibility and the DNA Damage Response
Đapic, V., Carvalho, M. A., & Monteiro, Á. N. A. (2005) · Cancer Control · doi:10.1177/107327480501200210 · Cited by 49
A never-ending story: the steadily growing family of the FA and FA-like genes
Gueiderikh, A., Rosselli, F., & Neto, J. B. C. (2017) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2016-0213 · Cited by 50
Li, Q., Saito, T. T., Deshong, A. J., Martínez García, M., Nadarajan, S., Lawrence, K. S., Checchi, P. M., Colaiácovo, M. P., & Engebrecht, J. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007701 · Cited by 50
BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites
Hu, Z., Mi, S., Zhao, T. S., Peng, C., Peng, Y., Chen, L., Zhu, W., Yao, Y., Song, Q., Li, X., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104133 · Cited by 49
The Functions of MutL in Mismatch Repair
Guarné, A. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-387665-2.00003-1 · Cited by 49
FANCM–FAAP24 and FANCJ: FA proteins that metabolize DNA
Ali, A. M., Singh, T. R., & Meetei, A. R. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.04.002 · Cited by 47
Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy
Andreassen, P. R., & Ren, K. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909787314011 · Cited by 50
BRCT Domains: phosphopeptide binding and signaling modules
María, C. (2008) · Frontiers in bioscience · doi:10.2741/3125 · Cited by 51
BRCA1 interacts with FHL2 and enhances FHL2 transactivation function
Yan, J., Zhu, J., Zhong, H.-J., Lu, Q., Huang, C., & Ye, Q. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00978-5 · Cited by 46
Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1
Hernández, G., Ramı́rez, M. J., Minguillón, J., Quiles, P., Ponce, G. R. D. G., Aza‐Carmona, M., Bogliolo, M., Pujol, R. M., Prados‐Carvajal, R., Fernández‐Rodríguez, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03433-3 · Cited by 49
Skibbens, R. V. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503129 · Cited by 47
Wu, J., Liu, C., Chen, J., & Yu, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.351007 · Cited by 48
Untangling the crosstalk between BRCA1 and R-loops during DNA repair
Alonso, M. S. M., & Noordermeer, S. M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab178 · Cited by 45
kConFab, Tischkowitz, M. D., Hamel, N., Carvalho, M. A., Birrane, G., Soni, A., van Beers, E. H., Joosse, S. A., Wong, N., Novak, D. J., et al. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.13 · Cited by 45
Simeonov, A. M., Yasgar, A., Jadhav, A., Lokesh, G. L.-R., Klumpp-Thomas, C. A., Michael, S., Austin, C. P., Natarajan, A., & Inglese, J. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.11.039 · Cited by 45
Studies of TBX4 and chromosome 17q23.1q23.2: An uncommon cause of nonsyndromic clubfoot
Lu, W., Bacino, C. A., Richards, B. S., Alvarez, C. M., VanderMeer, J. E., Vella, M., Ahituv, N., Sikka, N., Dietz, F. R., Blanton, S. H., et al. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35418 · Cited by 44
FANCJ/BACH1 Acetylation at Lysine 1249 Regulates the DNA Damage Response
Xie, J., Peng, M., Guillemette, S., Quan, S., Maniatis, S., Wu, Y., Venkatesh, A., Shaffer, S. A., Brosh, R. M., & Cantor, S. B. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002786 · Cited by 44
Self-citationUSP9X stabilizes BRCA1 and confers resistance to DNA‐damaging agents in human cancer cells
Lu, Q., Zhang, F.-L., Lu, D., Shao, Z., & Li, D. (2019) · Cancer Medicine · doi:10.1002/cam4.2528 · Cited by 43
Fine mapping of a multiple sclerosis locus to 2.5 Mb on chromosome 17q22-q24
Saarela, J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.19.2257 · Cited by 43
Age-related gene and miRNA expression changes in airways of healthy individuals
Ong, J., Woldhuis, R. R., Boudewijn, I. M., van den Berg, A., Kluiver, J. L., Kok, K., Terpstra, M. M., Guryev, V., de Vries, M., Vermeulen, C. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39873-0 · Cited by 43
Helicases FANCJ, RTEL1 and BLM Act on Guanine Quadruplex DNA in Vivo
Lansdorp, P. M., & van Wietmarschen, N. (2019) · Genes · doi:10.3390/genes10110870 · Cited by 42
Loman, N., Bladström, A., Johannsson, O. T., Borg, Å., & Olsson, H. L. (2003) · Breast Cancer Research · doi:10.1186/bcr632 · Cited by 43
Eelen, G., Vanden Bempt, I., Verlinden, L., Drijkoningen, M., Smeets, A., Neven, P., Christiaens, M. R., Marchal, K., Bouillon, R., & Verstuyf, A. (2008) · Oncogene · doi:10.1038/onc.2008.51 · Cited by 41
Gupta, R., Sharma, S., Doherty, K. M., Sommers, J. A., Cantor, S. B., & Brosh, R. M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl964 · Cited by 41
Self-citationBRCA1 16 years later: DNA damage‐induced BRCA1 shuttling
Yang, E. S.-H., & Xia, F. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07734.x · Cited by 41
Fanconi anemia: at the Crossroads of DNA repair
Deakyne, J. S., & Mazin, A. V. (2011) · Biochemistry (Moscow) · doi:10.1134/s0006297911010068 · Cited by 40
DNA helicases and their roles in cancer
Dhar, S., Datta, A., & Brosh, R. M. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102994 · Cited by 42
Factors forming the BRCA1-A complex orchestrate BRCA1 recruitment to the sites of DNA damage
Her, J., Lee, N. S., Kim, Y., & Kim, H. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw047 · Cited by 43
Rudra, S., & Skibbens, R. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075435 · Cited by 42
FANCJ: Solving problems in DNA replication
Hiom, K. J. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.01.005 · Cited by 41
New Players in the BRCA1-mediated DNA Damage Responsive Pathway
Kim, H., & Chen, J. (2008) · Molecules and Cells · doi:10.1016/s1016-8478(23)17605-9 · Cited by 41
Oishi, H., Kitagawa, H., Wada, O., Takezawa, S., Tora, L., Kouzu‐Fujita, M., Takada, I., Yano, T., Yanagisawa, J., & Kato, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510157200 · Cited by 45
RetractedOpportunities and hurdles in the treatment of BRCA1-related breast cancer
Drost, R., & Jonkers, J. (2013) · Oncogene · doi:10.1038/onc.2013.329 · Cited by 44
Nelson, A., & Holt, J. T. (2010) · Radiation Research · doi:10.1667/rr1290.1 · Cited by 40
Phosphopeptide interactions with BRCA1 BRCT domains: More than just a motif
Wu, Q., Jubb, H. C., & Blundell, T. L. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.02.003 · Cited by 40
DNA Helicases Associated with Genetic Instability, Cancer, and Aging
Suhasini, A. N., & Brosh, R. M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5037-5_6 · Cited by 43
BRCA1 and BRCA2 in hereditary breast cancer
Scully, R., & Puget, N. (2002) · Biochimie · doi:10.1016/s0300-9084(01)01359-1 · Cited by 46
Assessing the Link between BACH1 and BRCA1 in the FA Pathway
Cantor, S. B., & Andreassen, P. R. (2005) · Cell Cycle · doi:10.4161/cc.5.2.2338 · Cited by 39
Self-citationBRCAs, I., Guénard, F., Labrie, Y., Ouellette, G., Joly Beauparlant, C., Simard, J., & Durocher, F. (2008) · Journal of Human Genetics · doi:10.1007/s10038-008-0285-z · Cited by 38
Sun, X., Brieño‐Enríquez, M. A., Cornelius, A. J., Modzelewski, A. J., Maley, T. T., Campbell-Peterson, K. M., Holloway, J. K., & Cohen, P. E. (2015) · Chromosoma · doi:10.1007/s00412-015-0549-2 · Cited by 40
Wu, Y., Sommers, J. A., Loiland, J., Kitao, H., Kuper, J., Kisker, C., & Brosh, R. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.351338 · Cited by 39
C. elegans: A model of Fanconi anemia and ICL repair
Youds, J. L., Barber, L. J., & Boulton, S. J. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.007 · Cited by 37
BRCA1 in hormone-responsive cancers
Rosen, E. M., Fan, S., Pestell, R. G., & Goldberg, I. D. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2003.08.001 · Cited by 38
Cao, A.-Y., Huang, J., Hu, Z., Li, W.-F., Ma, Z.-L., Tang, L.-L., Zhang, B., Su, F.-X., Zhou, J., Di, G.-H., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0052-z · Cited by 37
Ma, X., Cai, G. Q., Zou, W., Huang, Y. H., Zhang, J. R., Wang, D. T., & Chen, B. L. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.089 · Cited by 38
Na, Z., Pan, S., Uttamchandani, M., & Yao, S. Q. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201405169 · Cited by 38
Dohrn, L., Salles, D. C., Siehler, S. Y., Kaufmann, J., & Wiesmüller, L. (2011) · Biochemical Journal · doi:10.1042/bj20110314 · Cited by 41
Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer
Aloraifi, F., Boland, M. R., Green, A., & Geraghty, J. (2015) · Surgical Oncology · doi:10.1016/j.suronc.2015.04.003 · Cited by 40
Hereditary Breast Cancer in the Han Chinese Population
Cao, W., Wang, X., & Li, J. (2013) · Journal of Epidemiology · doi:10.2188/jea.je20120043 · Cited by 37
Wu, Y., & Brosh, R. M. (2009) · Current Molecular Medicine · doi:10.2174/156652409788167159 · Cited by 37
Cortical neurons gradually attain a post-mitotic state
de Anda, F. C., Madabhushi, R., Rei, D., Meng, J., Gräff, J., Durak, O., Meletis, K., Richter, M., Schwanke, B., Mungenast, A. E., et al. (2016) · Cell Research · doi:10.1038/cr.2016.76 · Cited by 36
Regulation of the DNA Damage Response to DSBs by Post-Translational Modifications
Oberle, C., & Blattner, C. (2010) · Current Genomics · doi:10.2174/138920210791110979 · Cited by 37
HapScope: a software system for automated and visual analysis of functionally annotated haplotypes
Zhang, J. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf654 · Cited by 35
BACH1 Ser919Pro variant and breast cancer risk
Vahteristo, P., Uusi-Rauva, K., Tamminen, A., Eerola, H., BLOMQVIST, C. P., & Nevanlinna, H. A. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-19 · Cited by 35
Structural basis for phosphorylation-dependent signaling in the DNA-damage response
Williams, R. S., Bernstein, N. K., Lee, M. S., Rakovszky, M. L., Cui, D., Green, R., Weinfeld, M., & Glover, J. N. M. (2005) · Biochemistry and Cell Biology · doi:10.1139/o05-153 · Cited by 34
Adamovich, A. I., Diabate, M., Banerjee, T., Nagy, G., Smith, N. T., Duncan, K., Mendoza, E. M., Ajo, G. P., Freitas, M. A., Starita, L. M., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.01.019 · Cited by 36
Metadata
- Authors
- Cantor, S. B., Bell, D. W., Ganesan, S., Kass, E. M., Drapkin, R., Grossman, S., Wahrer, D. C. R., Sgroi, D. C., Lane, W. S., Haber, D. A., & Livingston, D. M.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Livingston, David M.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 105
- Issue
- 1
- Pages
- 149-160
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2109173575
- Cited by
- 674
- References
- 61
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 20 · 2023: 25 · 2022: 17 · 2021: 32 · 2020: 23 · 2019: 27 · 2018: 14 · 2017: 20 · 2016: 33 · 2015: 29 · 2014: 24 · 2013: 21 · 2012: 35
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (T32HL007627, T32-HL07627-16)
- National Cancer Institute (P50 CA 89393, P50CA089393)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BACH1, BRCA1, protein-protein interaction, DNA double-strand break repair, homologous recombination, germline mutations, early-onset breast cancer, cancer susceptibility genes
- MeSH terms
- Adult, Binding Sites, Boston, Breast Neoplasms, Cell Line, Chromosomes, Human, Pair 17, DNA Repair, DNA Helicases, DNA-Binding Proteins, Female, Genetic Testing, Humans, Molecular Sequence Data, Protein Binding, Recombinant Fusion Proteins, Transfection, Mutagenesis, Site-Directed, Sequence Homology, Amino Acid, Protein Structure, Tertiary, BRCA1 Protein, Genetic Predisposition to Disease, RNA Helicases, Amino Acid Motifs, Spectrometry, Mass, Electrospray Ionization, Fanconi Anemia Complementation Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
